11.06.2020 | Correction
Correction to: Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization
Erschienen in: Cancer Chemotherapy and Pharmacology | Ausgabe 1/2020
Einloggen, um Zugang zu erhalten